Publikationer

Sortér efter: Dato | Forfatter | Titel

Gane, E. J., Pianko, S., Roberts, S. K., Thompson, A. J., Zeuzem, S., Zuckerman, E., Ben-Ari, Z., Foster, G. R., Agarwal, K., Laursen, A. L., Gerstoft, J., Gao, W., Huang, H.-C., Fitzgerald, B., Fernsler, D., Li, J. J., Grandhi, A., Liu, H., Su, F.-H. ... Esteban, R. (2017). Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials. The Lancet Gastroenterology and Hepatology, 2(11), 805-813. https://doi.org/10.1016/S2468-1253(17)30159-0
Larsen, C. S. (2017). Sekundære immundefekter. I C. K. Holm (red.), Immunologi (1 udg., Bind 1). FADL's Forlag.
Vibholm, L., Schleimann, M. H., Højen, J. F., Benfield, T., Offersen, R., Rasmussen, K., Olesen, R., Dige, A., Agnholt, J., Grau, J., Buzon, M. J., Wittig, B., Lichterfeld, M., Petersen, A. M., Deng, X., Abdel-Mohsen, M., Pillai, S. K., Rutsaert, S., Trypsteen, W. ... Søgaard, O. S. (2017). Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection. Clinical Infectious Diseases, 64(12), 1686-1695. https://doi.org/10.1093/cid/cix201
Dalgard, O., Weiland, O., Noraberg, G., Karlsen, L., Heggelund, L., Färkkilâ, M., Balslev, U., Belard, E., Øvrehus, A., Skalshøi Kjær, M., Krarup, H., Thorup Røge, B., Hallager, S., Madsen, L. G., Lund Laursen, A., Lagging, M. & Weis, N. (2017). Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study. PLoS One, 12(7), e0179764. Artikel e0179764. https://doi.org/10.1371/journal.pone.0179764
Jensen, M. M., Olesen, J. S., Jespersen, S., Kjerulff, B., Silva, Z. J. D., Rodrigues, A., Aaby, P., Wejse, C., Erikstrup, C. & Hønge, B. L. (2017). Stabilizing prevalence of HTLV despite decreasing HIV prevalence – 20 years of retroviral surveillance in Guinea-Bissau, West Africa.. Poster-session præsenteret på 34th Annual Conference of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID), Torshavn, Færøerne.